Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00392938 · ClinicalTrials.gov registry record

Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone

A clinical trial, sponsored by University of Washington.

Completed
Registry status
11
Enrollment target

NCT00392938: Completed study, sponsored by University of Washington.

NCT00392938 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00392938 has completed, sponsored by University of Washington.

COMPLETED
Registry status
11 participants
Enrollment target

Study Summary

RATIONALE: Imaging procedures, such as PET scan, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying carbon-11 acetate and fludeoxyglucose F 18 PET scan of the bone in patients with metastatic prostate cancer that has spread to the bone.

Interventions

  • DRUG docetaxel
  • DRUG antiandrogen therapy
  • DIAGNOSTIC_TEST C-11 acetate PET scan
  • DIAGNOSTIC_TEST F-18 FDG PET scan
  • DIAGNOSTIC_TEST Tc-99m bone scan

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2005-12
University of Washington

1,048 total trials

What the finished NCT00392938 record still lists

NCT00392938 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which docetaxel is the first listed.

NCT00392938 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00392938 about?

NCT00392938 is a clinical study titled "Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone". RATIONALE: Imaging procedures, such as PET scan, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying carbon-11 acetate and fludeoxyglucose F 18 PET scan of the bone in patients with metastatic prostate cancer that has...

What is the current status of trial NCT00392938?

This trial is currently completed. The enrollment target is 11 participants. The study started on 2005-12.

What interventions are being tested in trial NCT00392938?

The interventions under investigation include: docetaxel (DRUG), antiandrogen therapy (DRUG), C-11 acetate PET scan (DIAGNOSTIC_TEST), F-18 FDG PET scan (DIAGNOSTIC_TEST), Tc-99m bone scan (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT00392938?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00392938, the US trial registry maintained by the National Library of Medicine. NCT00392938 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.